Scientists have identified a genetic signature that appears to reflect the risk of tumor recurrence or spread in men surgically treated for prostate cancer. If confirmed, the finding not only may help determine which patients require additional treatment after surgery, it also may help address the most challenging problem in prostate cancer treatment — distinguishing tumors that require aggressive treatment from those that can safely be monitored.